Alkeon Capital Management’s Acceleron Pharma XLRN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q4 | – | Sell |
|
|||||
2021
Q3 | $214M | Sell |
|
|||||
2021
Q2 | $157M | Sell |
|
|||||
2021
Q1 | $233M | Buy |
|
|||||
2020
Q4 | $220M | Buy |
|
|||||
2020
Q3 | $183M | Buy |
|
|||||
2020
Q2 | $143M | Buy |
|
|||||
2020
Q1 | $124M | Buy |
|
|||||
2019
Q4 | $30.6M | Sell |
|
|||||
2019
Q3 | $37.3M | Hold |
|
|||||
2019
Q2 | $38.8M | Buy |
|
|||||
2019
Q1 | $39.3M | Buy |
|
|||||
2018
Q4 | $16.3M | Buy |
|
|||||
2018
Q3 | $15.6M | Buy |
|